Yahoo! Canada Finance: Biotechnology Industry News

Gloucester Pharmaceuticals to Present Positive Results from Multiple Studies of ISTODAX® at the ASH Annual Meeting

Tue, 24 Nov 2009 20:15:43 GMT

Business Wire - Gloucester Pharmaceuticals today announced multiple presentations from clinical and preclinical studies of ISTODAX® (romidepsin) at the upcoming 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, Louisiana, at the Ernest N.

Merck Announces Quarterly Dividends and New $3 Billion Share Repurchase Program

Tue, 24 Nov 2009 20:10:54 GMT

Business Wire - At their meeting today, the Board of Directors of Merck & Co., Inc. declared a quarterly dividend of $0.38 per share on the company’s common stock for the first quarter of 2010.

Abiomed to Present at the 21st Annual Piper Jaffray Healthcare Conference

Tue, 24 Nov 2009 20:06:29 GMT

Business Wire - Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R.

Tennessee Biotechnology Association Announces Integrative Biotechnology Workshop

Tue, 24 Nov 2009 19:10:25 GMT

Business Wire - The Tennessee Biotechnology Association and its Graduate Alliance are jointly hosting an afternoon of biotech, business, and law on December 7th, 2009.

Signature Genomic Laboratories CEO Lisa G. Shaffer, Ph.D., Named Ernst & Young LLP Entrepreneur Of The Year® Award 2009 National Finalist in Health Sc

Tue, 24 Nov 2009 19:07:06 GMT

Business Wire - Signature Genomic Laboratories, LLC, announced that President and CEO Lisa G. Shaffer, Ph.D.,...

Synovis Life Technologies Welcomes Patrick L. Horan as Its Vice President of Sales for the Surgical Group

Tue, 24 Nov 2009 18:09:12 GMT

Business Wire - Synovis Life Technologies, Inc. (Nasdaq: SYNO), announced today that it has hired Patrick L.

Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds

Tue, 24 Nov 2009 18:00:22 GMT

PRNewswire - Dow AgroSciences Canada announced today it is acquiring the assets of Hyland Seeds, a division of Thompsons Limited of Blenheim, Ontario.

SpineGuard elects founder of Danek Medical, Alan Olsen, as a director

Tue, 24 Nov 2009 17:43:28 GMT

Business Wire - SpineGuard, a medical device start-up, announced today that it has elected well-known medtech industry entrepreneur and investor Alan Olsen as a director, effective immediately.

Medifacts Inks $1.6 Million Diabetes Study with Top Five Pharmaceutical Company

Tue, 24 Nov 2009 17:03:39 GMT

Business Wire - MEDIFACTS INTERNATIONAL, INC. one of the largest global providers of noninvasive cardiac diagnostic services today announced the award of a $1.6 million contract with a top five pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large, late-stage clinical trial.

NIPTE Receives FDA Contract to Develop Educational Program in State-of-the-Art Pharmaceutical Manufacturing Science for FDA Reviewers

Tue, 24 Nov 2009 17:01:02 GMT

Business Wire - The U.S. Food and Drug Administration (FDA) has awarded the National Institute for Pharmaceutical...

Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference

Tue, 24 Nov 2009 16:41:29 GMT

CNW Group - Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that Patrick T.

Global General Technologies (GLGT) Announces 32% Reduction of Shares Outstanding Rescission of Merger with ITI Biotech and (MONA)

Tue, 24 Nov 2009 16:30:15 GMT

PRNewswire - Global General Technologies Inc. (GLGT; ht tp://www.glgt-corporate.com/) announced today the rescission of the purchase of the ITI Biotech Inc. (http://www.nuayre.com/) with the Monarc Corp. (MONA; http://www.monacorporation.com/) Global General Technologies Inc. had purchased ITI Biotech Inc. on April 3, 2009, on a stock purchase basis for 277,777 million shares at 0.009 (2.5 million USD).

PROLOR Biotech Reports Merck Receives Positive Regulatory Opinion for European Marketing of Long-Acting CTP-Modified Fertility Treatment ELONVA(R) (FS

Tue, 24 Nov 2009 16:05:44 GMT

PRNewswire - PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the positive opinion by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for marketing approval in Europe for ELONVA(R), a long-acting CTP-modified version of the fertility hormone FSH from Merck & Co.

Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase

Tue, 24 Nov 2009 15:55:09 GMT

PRNewswire - Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production in Xi'an, China, today reported that in its third quarter, the company realized a 26% increase in revenues.

Emerging Stock Report Initiates Independent Research Coverage on AEterna Zentaris Inc.

Tue, 24 Nov 2009 15:48:30 GMT

GlobeNewswire - Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on AEterna Zentaris Inc., (Nasdaq:AEZS).

Advanced Cell Technology to Present at LD Micro Conference in Los Angeles

Tue, 24 Nov 2009 15:38:06 GMT

Business Wire - Advanced Cell Technology, Inc. (OTCBB:ACTC), a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it will present at the LD Micro Conference on Thursday December 3, 2009 at 4:30 p.m. (PST) at the Luxe Hotel in Los Angeles.

NeurogesX to Present at Piper Jaffray Health Care Conference

Tue, 24 Nov 2009 15:30:10 GMT

PRNewswire - NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at the 21st Annual Piper Jaffray Health Care Conference, to be held December 1-2, 2009 at The New York Palace Hotel in New York, New York.

Biolaxy Secures IND Approval for Oral Insulin

Tue, 24 Nov 2009 15:30:09 GMT

PRNewswire - Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes.

Research and Markets: Global Stem Cell and Advanced Technologies Market - Estimated to Be $88.3 Billion by 2014

Tue, 24 Nov 2009 15:02:09 GMT

Business Wire - Research and Markets (http://www.researchandmarkets.com/resea rch/848d75/global_stem_cell_a) has announced the addition of the "Global Stem Cell and Advanced Technologies Market" report to their offering.

ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition

Tue, 24 Nov 2009 15:00:27 GMT

Business Wire - ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that presentations of clinical data for three product candidates employing its Targeted Antibody Payload (TAP) technology will be made at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition to be held in New Orleans, LA, on December 5-8, 2009.

iCAD Announces Schedule of Events and Featured Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the 2009 RSNA

Tue, 24 Nov 2009 14:59:59 GMT

Business Wire - iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announces its schedule of events at the 95th annual meeting of the Radiological Society of North America (RSNA) in Chicago, from November 29 through December 4, 2009.

deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court

Tue, 24 Nov 2009 14:37:15 GMT

PRNewswire - deCODE genetics, Inc. (Nasdaq:DCGN) today announced the approval of all of its "first day" motions by the U.S.

Global Pharmaceuticals Awards Grant to Myasthenia Gravis Alliance

Tue, 24 Nov 2009 14:32:05 GMT

Business Wire - Global Pharmaceuticals, the generic products division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced their cooperation in awarding a modest grant to Myasthenia Gravis Alliance, also known as Myasthenia Gravis Foundation of Greater New York, Inc., a 501(3)(c) non profit membership corporation, incorporated in the State of New York.

Emisphere Technologies to Present at the New York Society of Security Analysts 13th Annual Biotech & Specialty Pharma Investment Conference

Tue, 24 Nov 2009 14:19:36 GMT

Business Wire - Emisphere Technologies, Inc. (OTC BB: EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its Eligen® Technology, today announced that President and Chief Executive Officer, Michael V. Novinski, will present a corporate overview at the 13th Annual Biotech & Specialty Pharma Investment Conference, sponsored by the New York Society of Securities Analysts, at 11:30 AM on December 1, 2009.

Biotracker LIMS Receives caBIG® Bronze Compatibility Certification

Tue, 24 Nov 2009 14:17:25 GMT

Business Wire - Ocimum Biosolutions today announced that its specialty life science Laboratory Information Management System (LIMS), Biotracker™ has been awarded the prestigious caBIG® (cancer Biomedical Informatics Grid®) Bronze Compatibility Certification by the National Cancer Institute, an institute of the National Institutes of Health, U.S.

Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread® for Chronic Hepatitis B in Key Asian Countries

Tue, 24 Nov 2009 14:16:34 GMT

Business Wire - Gilead Sciences, Inc. (Nasdaq:GILD) and GlaxoSmithKline (NYSE:GSK) today announced a licensing agreement to commercialize Viread® (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B (HBV) infection in adults in five countries in Asia.

NDIS Approval of Promega PowerPlex® Kit Clears Path for More DNA Profiles to be Added to U.S. Database

Tue, 24 Nov 2009 14:10:36 GMT

Business Wire - The FBI recently approved the Promega PowerPlex® 16 HS System for use by laboratories participating in, or generating DNA records for, the National DNA Index System (NDIS).

Advanced BioHealings Kevin Rakin to Present at 21st Annual Piper Jaffray Health Care Conference

Tue, 24 Nov 2009 14:05:01 GMT

Business Wire - Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that Chairman and Chief Executive Officer Kevin Rakin will present at the 21st Annual Piper Jaffray Health Care Conference.

Depomed to Present at Piper Jaffrays 21st Annual Health Care Conference

Tue, 24 Nov 2009 14:02:23 GMT

Business Wire - Depomed, Inc. (NASDAQ:DEPO) announced today that its president and chief executive officer, Carl A.

Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada

Tue, 24 Nov 2009 14:01:29 GMT

PRNewswire - Health Robotics today announced that it has formed a new Canadian joint venture with a group of selected investors.

BK Medical Announces New Three-Year Agreement with MedAssets

Tue, 24 Nov 2009 14:01:27 GMT

Business Wire - BK Medical, an innovative leader in medical ultrasound and a wholly owned subsidiary of Analogic Corporation (NASDAQ:ALOG), has signed a new three-year product-line agreement with MedAssets Supply Chain Systems. This agreement enables BK Medical's urological and surgical ultrasound systems, related accessories, and supplies to be available to more than 1,700 MedAssets healthcare provider customers who utilize the MedAssets group purchasing organization (GPO) services.

BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference

Tue, 24 Nov 2009 14:00:53 GMT

PRNewswire - BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming Piper Jaffray 21st Annual Health Care Conference on Tuesday, December 1, 2009, at 3:30pm ET at The New York Palace Hotel in New York, NY.

Piper Jaffray Hosts 21st Annual Health Care Conference

Tue, 24 Nov 2009 13:41:30 GMT

Business Wire - Piper Jaffray will host its 21st annual Health Care Conference December 1 – 2 in New York.

Exelixis Announces Webcast of Its Fifth Annual R&D Day on December 2

Tue, 24 Nov 2009 13:35:48 GMT

Business Wire - Exelixis, Inc. (NASDAQ:EXEL) announced today that it will hold its Fifth Annual R&D Day on Wednesday, December 2, 2009 from 10:00 a.m.

CytRx Announces Plan to Initiate a Phase 2 Clinical Trial with INNO-206 in Patients with Advanced Soft Tissue Sarcomas

Tue, 24 Nov 2009 13:31:44 GMT

Business Wire - CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.

AVANIR Pharmaceuticals Announces Fiscal 2009 Fourth Quarter and Full Year Financial Results

Tue, 24 Nov 2009 13:30:26 GMT

Business Wire - AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today reported unaudited financial results for the three and twelve months ended September 30, 2009.

Bio-Solutions Corp. Announces the Nomination of a Prestigious Member to Its Advisory Committee.

Tue, 24 Nov 2009 13:30:21 GMT

Marketwire - Bio-Solutions Corp. (OTCBB:BISU), is pleased to announce the nomination of a prestigious member to its advisory committee.

Swish and Enviro-Solutions to Launch SDC-Based Disinfectants in Canada and US

Tue, 24 Nov 2009 13:27:50 GMT

Business Wire - PURE Bioscience (NASDAQ:PURE) today announced an agreement with Charlotte Products Ltd. whereby Charlotte Products will blend and package PURE’s patented silver dihydrogen citrate (SDC)-based hard surface disinfectant, which will be distributed in Canada and the US through Swish Maintenance Limited, Swish (USA) and Enviro-Solutions Limited.

Pall Corporation Establishes New European Headquarters

Tue, 24 Nov 2009 13:13:32 GMT

Business Wire - Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today inaugurated its new European headquarters in Fribourg, Switzerland.

Roche and the Department of Health of Junta de Andalucía Collaborate in Spanish Medical Genome Project

Tue, 24 Nov 2009 13:06:07 GMT

Business Wire - Roche (SIX: RO, ROG; OTCQX: RHHBY) and the Department of Health of Junta de Andalucía, Spain have signed an agreement for a cooperation in the Medical Genome Project (MGP), a research project created to analyse the genomes of people with rare diseases and identify the defective gene or genes causing the disease and its behaviour.

Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference

Tue, 24 Nov 2009 13:00:55 GMT

PRNewswire - Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 at 11:30 a.m.

Genomic Health to Present at Piper Jaffray Health Care Conference

Tue, 24 Nov 2009 13:00:38 GMT

PRNewswire - Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Genomic Health's Executive Chairman, will present at the 21st Annual Piper Jaffray Health Care Conference in New York City on Tuesday, December 1, 2009 at 10:00 a.m.

Afexa Appoints Two New Members to Its Board of Directors

Tue, 24 Nov 2009 13:00:25 GMT

Marketwire - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) maker of COLD-FX(R), announced the appointment of John A.

Clinical Data, Inc. to Present at Piper Jaffray Health Care Conference

Tue, 24 Nov 2009 12:51:45 GMT

Business Wire - Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a brief corporate overview at the 21st Annual Piper Jaffray Health Care Conference.

CombinatoRx Oncology Programs to Be Highlighted at ASH 2009

Tue, 24 Nov 2009 12:32:44 GMT

Business Wire - CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that two abstracts highlighting data on its A2A and Beta-2 Adrenergic Receptor Agonist oncology programs have been accepted for presentation at the American Society for Hematology (ASH) 2009 Annual Meeting in New Orleans on December 5-8, 2009.

Medtronic Second Quarter Revenue Increases 8% to $3.838 Billion; Raises EPS Guidance for Current Fiscal Year

Tue, 24 Nov 2009 12:15:39 GMT

Business Wire - Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2010, which ended Oct. 30, 2009.

Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease

Tue, 24 Nov 2009 12:06:33 GMT

PRNewswire - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has submitted a MAA to the European Medicines Agency for velaglucerase alfa, the company's enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease.

Salix Pharmaceuticals to Present at Piper Jaffray Conference

Tue, 24 Nov 2009 12:05:58 GMT

Business Wire - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the Piper Jaffray 21st Annual Health Care Conference in New York, NY on Tuesday, December 1 at 10:00 a.m.

Click Commerce and the University of Texas at San Antonio Announce eResearch Strategy

Tue, 24 Nov 2009 12:02:53 GMT

Business Wire - Click Commerce announced today that the University of Texas at San Antonio (UTSA) will use the company’s eResearch Portal software to fully automate a variety of research administration and compliance processes, including those associated with Institutional Review Board (IRB), Institutional Animal Care and Use Committee (IACUC), and Conflict of Interest (COI).

Hamilton Thorne announces third quarter results

Tue, 24 Nov 2009 12:01:04 GMT

PRNewswire - Hamilton Thorne Ltd. (TSX-V: HTL), formerly Calotto Capital Inc., a leading provider of advanced laser systems and instruments for the stem cell research and fertility clinic markets, today reported operational and financial results for the third quarter ended September 30, 2009.

AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer

Tue, 24 Nov 2009 12:00:36 GMT

PRNewswire - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.

Acorda Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference

Tue, 24 Nov 2009 12:00:31 GMT

Business Wire - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present at the upcoming 21st Annual Piper Jaffray Health Care Conference on Wednesday, December 2, 2009 at 9:30 a.m.

The Automation Partnership Collaborates With Major European Biotech

Tue, 24 Nov 2009 10:30:22 GMT

Business Wire - The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, today announced its Advanced Projects Group has successfully collaborated with a major European antibody therapeutics company to deliver a custom automated protein purification and concentration system helping the company accelerate its pre-clinical research.

Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds

Tue, 24 Nov 2009 09:31:28 GMT

Business Wire - Oxagen Limited, a drug discovery and development company specializing in inflammation, announced today the successful completion of a £16 Million ($26.7 Million) Series C round led by Novartis Venture Funds.

Santarus to Present at Piper Jaffray 21st Annual Health Care Conference

Tue, 24 Nov 2009 09:01:13 GMT

Business Wire - Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, today announced that Gerald T.